Q3 2025 · 13F-HR
Data Collective IV GP, LLCholdings as filed
Filed 2025-11-14 · accession 0001104659-25-111909
$68.0M
Reported value
4
Positions
2025-09-30
Period end
The Brief · Data Collective IV GP, LLC · Q3 2025
AI · grounded in 13F
Data Collective IV GP, LLC closed its entire position in Rocket Lab Corp RKLB, reducing its holdings by $38.7M. The fund also trimmed its stake in Evolv Technologies Holdings, Inc. EVLV by 48.35%. These moves brought the fund's total assets under management to $67.98M across four positions.
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 30049H102 | EVLV | Evolv Technologies Holdings, Inc. | $37.8M | 55.5% | 5,000,000 | Common | SOLE |
| 75629V104 | RXRX | Recursion Pharmaceuticals, Inc. | $29.0M | 42.6% | 5,941,120 | Common | SOLE |
| 60255C885 | BRD1EUR | Mind Medicine (MindMed) Inc. | $1.2M | 1.74% | 100,350 | Common | SOLE |
| G76279101 | ROIV | Roivant Sciences Ltd. | $58,629 | 0.09% | 3,875 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.